{{Drugbox
| IUPAC_name = ''N''-[(8-fluoro-1-methyl-5-phenyl-2,3-dihydro-1''H''-1,4-benzodiazepin-2-yl)methyl]-3-furamide
| image = Lufuradom.svg
| CAS_number = 85118-42-9
| CAS_supplemental = 
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 3045400
| ChemSpiderID = 2308141
| C = 22 | H = 20 | F = 1 | N = 3 | O = 2
| molecular_weight = 377.412 g/mol
| smiles = O=C(C1=COC=C1)NCC2N(C)C3=C(C(C4=CC=CC=C4)=NC2)C=CC(F)=C3
| StdInChI = 1S/C22H20FN3O2/c1-26-18(13-25-22(27)16-9-10-28-14-16)12-24-21(15-5-3-2-4-6-15)19-8-7-17(23)11-20(19)26/h2-11,14,18H,12-13H2,1H3,(H,25,27)
| StdInChIKey = QJSCDZOUCFWCKD-UHFFFAOYSA-N
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
}}

'''Lufuradom''' ([[International Nonproprietary Name|INN]]) is a [[drug]] and [[benzodiazepine]] derivative which, unlike other benzodiazepines, is described as an [[analgesic]].<ref name="Organization1988">{{cite book | author = World Health Organization | title = International nonproprietary names (INN) for pharmaceutical substances, 1988: lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list | url = https://books.google.com/books?id=eMUjAQAAMAAJ&pg=PA252 | accessdate = 26 April 2012 | date = 31 December 1988 | publisher = World Health Organization | isbn = 978-92-4-056014-7 | page = 252}}</ref> Similarly to its [[structural analog|analogue]] [[tifluadom]], it was never marketed.

== See also ==
* [[Tifluadom]]
* [[GYKI-52895]], structural benzodiazepine which is a dopamine reuptake inhibitor without GABAergic function
* [[GYKI-52,466]], structural benzodiazepine which is an AMPAkine and glutamate antagonist without GABAergic function

== References ==
{{Reflist|2}}


{{Analgesics}}
{{Opioidergics}}
{{Benzodiazepines}}

[[Category:Carboxamides]]
[[Category:Analgesics]]
[[Category:Benzodiazepines]]
[[Category:Kappa agonists]]
[[Category:Opioids]]
[[Category:Fluoroarenes]]

{{analgesic-stub}}